Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,437 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07280156RecruitingPhase 2
Study of PRX-115 for gout with or without methotrexate
This trial tests a new medicine, PRX-115, given through a vein, to see if it lowers uric acid levels in people with gout who haven't had success with standard treatments. Some participants will also take methotrexate, and the results are compared to a placebo (a dummy infusion).
Glendale, ArizonaAges 18 years+ - NCT07285434Enrolling by invitationEarly Phase 1
Personalized vaccine for first-line advanced lung cancer
This study tests a personalized vaccine (Microlyvaq™) made just for your tumor, given together with standard chemo and immunotherapy (pembrolizumab). It is for people with advanced non-small cell lung cancer who have not yet started treatment for the advanced stage.
Thessaloniki, MacedoniaAges Any age - NCT07286890Recruiting
Beating Heart Bypass Surgery Study with Getinge Devices
This study follows patients who have a type of heart bypass surgery called 'beating heart' CABG, where a special Getinge device is used to keep the heart pumping during the operation. It helps doctors learn more about how well these devices work in real-world use.
Stockton, CaliforniaAges 22 years+ - NCT07284121Recruiting
Patient satisfaction and safety of Atezolizumab in routine care
This study tracks how well Atezolizumab (Tecentriq) works for people with certain lung or liver cancers in everyday medical practice. It helps doctors understand if patients are satisfied with their treatment and how it affects their quality of life.
KremsAges 18 years+ - NCT07284927RecruitingPhase 1
LV009 injection for blood and lymph cancers
This trial tests a new treatment called LV009, a type of CAR-T cell therapy, for people with certain blood cancers (like leukemia or lymphoma) that have CD19 on their cells. The therapy uses your own immune cells to fight the cancer.
Suzhou, JiangsuAges 18–70 - NCT07287631Recruiting
Testing a portable device for potassium and calcium levels
This study tests a new portable device that measures potassium and ionized calcium levels from a finger-stick blood sample. It may help doctors get faster results for people who need regular monitoring.
Albuquerque, New MexicoAges 18 years+ - NCT07287163Enrolling by invitationPhase 3
Long-term study of vormatrigine for epilepsy
This trial is for adults with epilepsy who have already taken vormatrigine in a previous study or through a special access program. It aims to collect ongoing safety and effectiveness information.
Miami, FloridaAges 18–85 - NCT07284420RecruitingPhase 2
Testing empasiprubart with efgartigimod for myasthenia gravis
This study adds a new drug called empasiprubart to the existing treatment efgartigimod for people with generalized myasthenia gravis (gMG) who have antibodies against acetylcholine receptors (AChR-Ab) and have only partially responded to efgartigimod. The goal is to see if the combination improves daily living more than efgartigimod alone.
Carlsbad, CaliforniaAges 18 years+ - NCT07279649Recruiting
Studying a stent for blood vessel disease
This study is tracking how well a specific stent (GORE® VIABAHN® VBX) works over time in people who need treatment for narrowed or blocked blood vessels. It aims to see if the stent helps keep blood flowing long-term.
MunichAges 18 years+ - NCT06865118Recruiting
Home management of heart issues in scleroderma
This study tests whether people with systemic sclerosis (scleroderma) and pulmonary arterial hypertension (PAH) can safely monitor their heart health at home using a smartphone or other internet-connected device. If you have PAH and are comfortable using technology, this trial may help make care more convenient.
OsloAges 18 years+ - NCT06884787Recruiting
New tooth-colored filling for front teeth: how well does it work?
This trial is testing a modern tooth-colored filling material for fixing cavities or gaps in front teeth. It looks at how well the filling performs and how satisfied patients are. You might be eligible if you need fillings in at least two front teeth and have generally healthy teeth and gums.
IrbidAges 18 years+ - NCT07283939Recruiting
Testing a tool to adjust chemo doses and reduce treatment delays
This trial tests a computer algorithm called PAGODA that helps doctors adjust chemotherapy doses for people with gastrointestinal cancers. The goal is to prevent unplanned treatment delays while keeping the treatment effective.
Fairbanks, AlaskaAges 18 years+ - NCT07283497RecruitingPhase 4
Itraconazole for bronchiectasis with airway mold growth
This Mayo Clinic study tests whether the oral antifungal drug itraconazole can help people with bronchiectasis who have mold growing in their airways. The goal is to see if it improves symptoms and reduces mold in the lungs.
Rochester, MinnesotaAges 18 years+ - NCT07287332Recruiting
BLOOM: Testing cefepime dosing in the ICU
This trial tests a way to give the antibiotic cefepime to ICU patients. It aims to see if the dosing can be adjusted more precisely for each person.
Rochester, MinnesotaAges 18 years+ - NCT07285044RecruitingPhase 2
Home cancer treatment program for Florida panhandle residents
This study tests whether people with certain cancers can safely receive their regular intravenous treatments at home instead of coming to the clinic. It aims to make treatment more convenient and improve satisfaction, especially for those living in the Florida Panhandle.
Jacksonville, FloridaAges 18 years+ - NCT07281859Recruiting
Heart monitor alert study for new ICD patients
This study tests a heart failure alert system called HeartInsight in people who recently received an ICD or CRT-D device. The goal is to see if the alerts help doctors manage care better. You may qualify if you got a new (not replacement) device less than a year ago.
Mercogliano, AvellinoAges 18 years+ - NCT07283315RecruitingEarly Phase 1
NK cell therapy for children with autoimmune diseases
This trial tests a new treatment using special NK cells (a type of immune cell) designed to target and calm overactive B cells that cause autoimmune diseases like lupus and kidney inflammation. It may help children whose current treatments aren't working well enough.
Hangzhou, ZhejiangAges 3 years+ - NCT07285863RecruitingPhase 4
How Secretin Changes Pancreatic Fluid in Healthy People
This study tests how a drug called secretin affects the fluid in your pancreas. It is for healthy people who are already having an endoscopic ultrasound for another reason.
Rochester, MinnesotaAges 18–80 - NCT07280260RecruitingPhase 4
Testing a new dental implant system for replacing a missing back tooth
This trial tests the Nobel N1 dental implant system in people missing a single back tooth. It aims to see how well the implant works when a replacement tooth is placed right away.
New Orleans, LouisianaAges 18 years+ - NCT07281794Recruiting
Testing a wearable system for walking and balance in Parkinson's
This study tests a wearable system (DANU Sports) that measures how you walk and keep your balance. It aims to see if the system can help people with Parkinson's disease track their movement problems.
Newcastle upon Tyne, Tyne and WearAges 50 years+ - NCT07284511RecruitingPhase 2/Phase 3
Tirzepatide for automatic blood sugar control in type 1 diabetes
This trial tests if adding tirzepatide (a once-weekly injection) to an automated insulin pump system (Control-IQ) helps adults with type 1 diabetes better manage their blood sugar. It requires using the Tandem Control-IQ pump and counting carbohydrates.
Montreal, QuebecAges 18 years+ - NCT07283042Recruiting
Studying a new way to classify placenta conditions
This trial tests a new classification system for placenta accreta spectrum (PAS), a condition where the placenta grows too deeply into the uterine wall. It aims to see if this system helps predict outcomes and improve care for pregnant people who need surgery for PAS.
Los Angeles, CaliforniaAges 18–55 - NCT07282691Recruiting
Validating eye tests for mild brain injury
This study looks at eye tests for people who had a mild brain injury (mTBI) in the last 1 to 6 months. It aims to better understand and measure eye movement problems that can happen after such an injury.
Philadelphia, PennsylvaniaAges 18–35 - NCT07279441Recruiting
Cochlear Implants and Listening Effort Study
This study looks at how much mental effort it takes for people with normal hearing or a cochlear implant to listen in different situations. Researchers want to learn how hearing and thinking work together, which could help improve cochlear implant technology.
Waltham, MassachusettsAges 18–80
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,437 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.